U.S. markets open in 6 hours 44 minutes
  • S&P Futures

    3,849.75
    +40.50 (+1.06%)
     
  • Dow Futures

    31,186.00
    +274.00 (+0.89%)
     
  • Nasdaq Futures

    13,124.75
    +213.75 (+1.66%)
     
  • Russell 2000 Futures

    2,239.10
    +39.90 (+1.81%)
     
  • Crude Oil

    62.68
    +1.18 (+1.92%)
     
  • Gold

    1,756.70
    +27.90 (+1.61%)
     
  • Silver

    27.16
    +0.72 (+2.72%)
     
  • EUR/USD

    1.2092
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3976
    +0.0054 (+0.38%)
     
  • USD/JPY

    106.5810
    +0.0790 (+0.07%)
     
  • BTC-USD

    46,151.49
    +1,461.96 (+3.27%)
     
  • CMC Crypto 200

    921.95
    -11.19 (-1.20%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

U.S. drug developer Raptor Pharmaceuticals explores sale -sources

April 6 (Reuters) - Raptor Pharmaceutical Corp, which develops drugs that treat orphan diseases, is in discussions with investment banks to hire a financial adviser to explore a potential sale, according to people familiar with the matter.

The move may not lead to a sale, the people said this week, asking not to be identified because the deliberations are confidential. Raptor did not respond to a request for comment.

(Reporting by Carl O'Donnell in New York; Editing by Leslie Adler)